Together-Breast Cancer Support Platform
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorCedars-Sinai Medical Center
About this trial
The goal of this study is to evaluate the acceptability and engagement of a culturally tailored online peer-support program for Korean speaking breast cancer patients and survivors. The main questions it aims to answer are: 1) Is the peer-support program acceptable and sustainable in terms of engagement between mentors and mentees over a 12-week period? 2) Does participation in the program improve quality of life, psychological well-being (including anxiety and depression), and perceived social support?
Participants will include Korean speaking breast cancer survivors (mentors) and patients currently undergoing treatment (mentees). After enrollment and matching based on screening information, participants will engage in peer-support interactions through an online platform for 12 weeks. Surveys will be administered at baseline, mid-point, post-intervention, and optional 6-month follow-up to assess outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years
Self-identify as Korean
Able to read, write, and speak both Korean and English
Diagnosed with breast cancer ≥ 2 years prior to enrollment
Disqualifiers
Individuals who do not meet the inclusion criteria
Individuals unable to use the online platform or required technology
Individuals deemed non-compliant or inappropriate for participation based on investigator judgment (e.g., inability to complete study procedures)
Mentees diagnosed with ductal carcinoma in situ (DCIS)
Trial population
The study population consists of Korean American breast cancer patients and survivors. Participants include mentors (breast cancer survivors diagnosed at least two years prior and who have completed treatment or are on long-term maintenance therapy) and mentees (patients currently undergoing active breast cancer treatment). All participants are required to have access to a smartphone or computer and be able to participate in an online peer-support platform. Participants will be recruited through community outreach, referrals, and self-referral using a QR code-based screening process.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
24 Participants
are grouped into 2 trial groupsGroup A: Mentors
Group B: Mentees
Trial outcomes
Primary outcomes
1
Feasibility of peer-support platform engagement
Feasibility is defined as the proportion of mentor-mentee pairs achieving at least one bidirectional interaction per week for at least 8 out of 12 weeks during the study period.
Time frame
Week 1 to Week 12Secondary outcomes
1
Change in quality of life (FACT-B score)
Quality of life will be assessed using the Functional Assessment of Cancer Therapy-Breast (FACT-B) questionnaire, which includes physical, social/family, emotional, and functional well-being domains.
Time frame
Baseline to Week 122
Change in social/family well-being (FACT-B social/family subscale)
Social/family well-being will be assessed using the social/family well-being subscale of the FACT-B questionnaire.
Time frame
Baseline to Week 123
Change in self-efficacy score
Self-efficacy will be assessed using the self-efficacy scale included in the study questionnaire administered at baseline, mid-study, and post-study.
Time frame
Baseline to Week 12Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: